Morgan Stanley stock underperforms Friday when compared to competitors
Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.
Gilead upgraded by Morgan Stanley on lenacapavir potential
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...
$1.2 Billion Morgan Stanley Team Thinks Dividend Investing Could Be Myopic
Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...
Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, ...
Morgan Stanley's Mike Wilson On Taking Risks – 'The Real Money Is Made With Contrarian Views'
Mike Wilson, Morgan Stanley's chief investment officer, has some advice for anyone looking to advance in their career: Take ...
bankingdive1d
Dive Deposits: Morgan Stanley’s MD promotions don’t set records, they follow the herd
While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...
Alcohol-Free Guinness Won’t Shield Diageo, Says Morgan Stanley
The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...
Morgan Stanley Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...
The tough-love advice Morgan Stanley CIO Mike Wilson gives to his new hires to prepare for their career in banking
"Everybody knows you made a mistake. How are you going to deal with that?" ...